Header Logo

Connection

JOSHUA COHEN to Quality-Adjusted Life Years

Back to Details
This is a "connection" page, showing publications JOSHUA COHEN has written about Quality-Adjusted Life Years.
JOSHUA COHEN
Connection Strength
0.969
Quality-Adjusted Life Years
  1. Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications. Value Health. 2022 01; 25(1):59-68.
    View in: PubMed
    Score: 0.181
  2. Measuring the Value of Prescription Drugs. N Engl J Med. 2015 Dec 31; 373(27):2595-7.
    View in: PubMed
    Score: 0.119
  3. Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses. Blood. 2015 Mar 19; 125(12):1866-9.
    View in: PubMed
    Score: 0.113
  4. Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014 Aug 28; 371(9):796-7.
    View in: PubMed
    Score: 0.110
  5. Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures. Value Health. 2013 Jun; 16(4):629-38.
    View in: PubMed
    Score: 0.100
  6. Are Medical Devices Cost-Effective? Appl Health Econ Health Policy. 2022 03; 20(2):235-241.
    View in: PubMed
    Score: 0.045
  7. Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs. J Gen Intern Med. 2020 09; 35(9):2629-2636.
    View in: PubMed
    Score: 0.041
  8. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value Health. 2018 07; 21(7):759-761.
    View in: PubMed
    Score: 0.035
  9. Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models. Med Decis Making. 2017 10; 37(7):790-801.
    View in: PubMed
    Score: 0.033
  10. The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients. Appl Health Econ Health Policy. 2017 Feb; 15(1):75-83.
    View in: PubMed
    Score: 0.032
  11. Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007. Med Care. 2016 Apr; 54(4):380-5.
    View in: PubMed
    Score: 0.031
  12. Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database. Biol Blood Marrow Transplant. 2015 Oct; 21(10):1823-9.
    View in: PubMed
    Score: 0.029
  13. The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma. J Natl Cancer Inst. 2015 Aug; 107(8).
    View in: PubMed
    Score: 0.029
  14. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012 Oct 02; 60(14):1271-7.
    View in: PubMed
    Score: 0.024
  15. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg. 2012 Oct; 56(4):1015-24.e1.
    View in: PubMed
    Score: 0.024
  16. A primer on cost-effectiveness analyses for vascular surgeons. J Vasc Surg. 2012 Jun; 55(6):1794-800.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.